Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record history shows a new latest revision (v3.5.4) replacing the previous (v3.5.3), indicating an update to the page's text and layout captured in the revision.
    Difference
    0.1%
    Check dated 2026-05-15T05:40:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer updates the displayed software revision from v3.5.2 to v3.5.3, reflecting a minor system/interface update rather than a change to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:08.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the history and v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:39.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The study record history shows the addition of revision v3.4.3 and the deletion of revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:28.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    An addition shows Revision: v3.4.2 in the history. A government-funding lapse notice and the entry for Revision: v3.4.1 were removed from the history.
    Difference
    0.8%
    Check dated 2026-02-11T14:00:20.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.